Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry.
- DOI
- 10.1080/09546634.2026.2700876
- Published
- 2026 Dec
- Container
- The Journal of dermatological treatment
- Publisher
- Not recorded
- Open access
- no
Credibility signals
uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/09546634.2026.2700876,
title = {Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry.},
author = {Rob F and Machovcová A and Jandová M and Tichý M and Vantuchová Y and Nečas M and Kojanová M and Cetkovská P and Třešňák Hercogová J and Gkalpakiotis S},
year = {2026},
journal = {The Journal of dermatological treatment},
doi = {10.1080/09546634.2026.2700876},
url = {https://doi.org/10.1080/09546634.2026.2700876}
}RIS
TY - JOUR TI - Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry. AU - Rob F AU - Machovcová A AU - Jandová M AU - Tichý M AU - Vantuchová Y AU - Nečas M AU - Kojanová M AU - Cetkovská P AU - Třešňák Hercogová J AU - Gkalpakiotis S PY - 2026 JO - The Journal of dermatological treatment DO - 10.1080/09546634.2026.2700876 UR - https://doi.org/10.1080/09546634.2026.2700876 ER -
APA
F, R., A, M., M, J., M, T., Y, V., M, N., M, K., P, C., J, T. H., & S, G. (2026). Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry.. The Journal of dermatological treatment. https://doi.org/10.1080/09546634.2026.2700876
Source records
- pubmed · retrieved 2026-09-26T15:24:38.018Z
- europe-pmc · retrieved 2026-09-26T15:24:38.006Z
- doaj · retrieved 2026-09-26T15:24:38.010Z